ClearPoint Neuro, Inc.
CLPT
$10.64
$0.141.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.59M | 32.24M | 31.39M | 30.43M | 28.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.59M | 32.24M | 31.39M | 30.43M | 28.07M |
| Cost of Revenue | 13.30M | 12.51M | 12.27M | 12.06M | 11.27M |
| Gross Profit | 20.30M | 19.73M | 19.12M | 18.37M | 16.80M |
| SG&A Expenses | 29.06M | 28.25M | 26.45M | 25.48M | 24.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.21M | 53.90M | 51.11M | 49.25M | 46.61M |
| Operating Income | -22.62M | -21.66M | -19.72M | -18.82M | -18.54M |
| Income Before Tax | -22.18M | -20.76M | -18.88M | -18.12M | -17.95M |
| Income Tax Expenses | 43.00K | 33.00K | 30.00K | 30.00K | 30.00K |
| Earnings from Continuing Operations | -22.22 | -20.79 | -18.91 | -18.15 | -17.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.22M | -20.79M | -18.91M | -18.15M | -17.98M |
| EBIT | -22.62M | -21.66M | -19.72M | -18.82M | -18.54M |
| EBITDA | -21.62M | -20.82M | -18.74M | -17.90M | -17.73M |
| EPS Basic | -0.80 | -0.75 | -0.70 | -0.69 | -0.71 |
| Normalized Basic EPS | -0.50 | -0.47 | -0.44 | -0.43 | -0.44 |
| EPS Diluted | -0.80 | -0.75 | -0.70 | -0.69 | -0.71 |
| Normalized Diluted EPS | -0.50 | -0.47 | -0.44 | -0.43 | -0.44 |
| Average Basic Shares Outstanding | 111.16M | 110.37M | 108.10M | 105.14M | 102.17M |
| Average Diluted Shares Outstanding | 111.16M | 110.37M | 108.10M | 105.14M | 102.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |